Filing Details
- Accession Number:
- 0001048477-24-000154
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-14 14:44:40
- Reporting Period:
- 2024-11-12
- Accepted Time:
- 2024-11-14 14:44:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1811096 | Greg Charles Guyer | C/O Biomarin Pharmaceutical Inc. 770 Lindaro Street San Rafael CA 94901 | Evp, Chief Technical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-10-31 | 55 | $56.01 | 74,187 | No | 5 | A | Direct | |
| Common Stock | Disposition | 2024-11-12 | 5,278 | $66.37 | 68,909 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents the shares acquired by the reporting person on October 31, 2024, pursuant to the issuer's Employee Stock Purchase Plan.
- The price in column 4 is the weighted average price. The purchase price actually received ranged from $66.37 to $66.395. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
Billionaire Hedge Funds
